We warmly congratulate Dr. Zhang Le from Guorui Yinuo on being awarded the title of High-Level Talent in Xi'an City and the 2022 Elite Innovation Talent Award.


Recently, Dr. Zhang Le, head of the institution and Deputy General Manager of Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd., received the "Certificate of Confirmation for High-Level Talents in Xi'an City" and the "Certificate of Selection for the Xi'an Talent Program—Elite Innovative Talent" issued by the Office of the Leading Group for Talent Work of the Xi'an Municipal Committee of the Communist Party of China.

 

Recently, Dr. Zhang Le, head of the institution and Deputy General Manager of Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd., received the "Certificate of Confirmation for High-Level Talents in Xi'an City" and the "Certificate of Selection for the Xi'an Talent Program" issued by the Office of the Leading Group for Talent Work of the Xi'an Municipal Committee of the Communist Party of China. - Elite Innovative Talents.

 

 

 

Under the leadership of Chairman Associate Professor Chen Mai, Head of the Institution Dr. Zhang Le, and General Manager Su Lai, Guo Rui Yinuo has now obtained approval from the National Medical Products Administration for its drug. GLP Certification, Veterinary Drugs by the Ministry of Agriculture and Rural Affairs of China GLP Certification, National Accreditation Commission CNAS GLP Certification. Guorui Yinuo will fully leverage its unique advantages and continue to apply for certifications across the entire pharmaceutical sector. GLP Qualification certification, followed by applying for international recognition. GLP Bilateral certification has established a convenient, efficient, and reliable technical platform for new drug research and preclinical safety evaluation in Shaanxi Province and across the country’s pharmaceutical industry, playing a crucial role in further enhancing the level of drug development, the pharmaceutical industry’s independent innovation capacity, and the quality of drug research.

 

Currently, Guorui Yinuo primarily provides customers with one-stop services including personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety evaluations, and clinical trial sample analysis.